Annual Revenue
$1.19 M
NaN%
December 31, 2023
Summary
- As of February 7, 2025, IOVA annual revenue is $1.19 million
- IOVA annual revenue is now at all-time high.
Performance
IOVA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$58.55 M
+$27.45 M+88.24%
September 30, 2024
Summary
- As of February 7, 2025, IOVA quarterly revenue is $58.55 million, with the most recent change of +$27.45 million (+88.24%) on September 30, 2024.
- Over the past year, IOVA quarterly revenue has increased by +$57.84 million (+8089.37%).
- IOVA quarterly revenue is now at all-time high.
Performance
IOVA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$90.86 M
+$58.09 M+177.24%
September 30, 2024
Summary
- As of February 7, 2025, IOVA TTM revenue is $90.86 million, with the most recent change of +$58.09 million (+177.24%) on September 30, 2024.
- Over the past year, IOVA TTM revenue has increased by +$88.95 million (+4671.90%).
- IOVA TTM revenue is now at all-time high.
Performance
IOVA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
IOVA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +8089.4% | +4671.9% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
IOVA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | at low | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | at low | at high | >+9999.0% | at high | >+9999.0% |
Iovance Biotherapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $58.55 M(+88.2%) | $90.86 M(+177.2%) |
| Jun 2024 | - | $31.11 M(+4250.5%) | $32.77 M(+1621.2%) |
| Mar 2024 | - | $715.00 K(+48.3%) | $1.90 M(+60.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $1.19 M | $482.00 K(+2.8%) | $1.19 M(+68.2%) |
| Sep 2023 | - | $469.00 K(+97.1%) | $707.00 K(+197.1%) |
| Jun 2023 | - | $238.00 K | $238.00 K |
FAQ
- What is Iovance Biotherapeutics annual revenue?
- What is the all time high annual revenue for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly revenue?
- What is the all time high quarterly revenue for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly revenue year-on-year change?
- What is Iovance Biotherapeutics TTM revenue?
- What is the all time high TTM revenue for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics TTM revenue year-on-year change?
What is Iovance Biotherapeutics annual revenue?
The current annual revenue of IOVA is $1.19 M
What is the all time high annual revenue for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual revenue is $1.19 M
What is Iovance Biotherapeutics quarterly revenue?
The current quarterly revenue of IOVA is $58.55 M
What is the all time high quarterly revenue for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly revenue is $58.55 M
What is Iovance Biotherapeutics quarterly revenue year-on-year change?
Over the past year, IOVA quarterly revenue has changed by +$57.84 M (+8089.37%)
What is Iovance Biotherapeutics TTM revenue?
The current TTM revenue of IOVA is $90.86 M
What is the all time high TTM revenue for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high TTM revenue is $90.86 M
What is Iovance Biotherapeutics TTM revenue year-on-year change?
Over the past year, IOVA TTM revenue has changed by +$88.95 M (+4671.90%)